Monday, June 23, 2025
25.7 C
Bengaluru

Draft Pharma Policy

[wpfilebase tag=file id=94 tpl=download-button /]

Inside this Issue

1. Draft Pharma Policy: The Good, The Bad and The Ugly  interview with Sunil Attavar

2. Career Brand Plan: A Career Stepping Stone by Soham Wagh

3. Succeeding as Country GM at GSK: A Whitepaper by Sunder Ramachandran

4. Role of Digital in the Customer Journey  by Salil Kallianpur

5. Executive Function Disorder  by Vivek Hattangadi

 

Hot this week

Top 25 Indian Pharma Companies by Revenues in 2024

India pharma is crucial for global healthcare, providing affordable...

Top 10 Indian Pharma – 2025

India's top 10 pharma companies by market capitalization, offering insights into...

Antibody-Drug Conjugates (ADCs): The Disruptors Leading Oncology’s Gold Rush in 2025

1. Market Overview The oncology sector remains the most dominant...

FLUX – Indian Pharma in the Post VUCA World

Introduction For decades, leaders and organizations have relied on the...

Topics

Top 25 Indian Pharma Companies by Revenues in 2024

India pharma is crucial for global healthcare, providing affordable...

Top 10 Indian Pharma – 2025

India's top 10 pharma companies by market capitalization, offering insights into...

Antibody-Drug Conjugates (ADCs): The Disruptors Leading Oncology’s Gold Rush in 2025

1. Market Overview The oncology sector remains the most dominant...

FLUX – Indian Pharma in the Post VUCA World

Introduction For decades, leaders and organizations have relied on the...

Indian Pharma Market (IPM) Highlights – January 2025

Overall IPM Performance: Monthly Growth: IPM monthly growth reached 8.4% in...

Role of AI Across Pharma Industry

Introduction Artificial intelligence (AI) is increasingly pivotal in driving innovation...
spot_img

Related Articles

spot_imgspot_img